MF研究者総覧

教員活動データベース

Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group.

発表形態:
原著論文
主要業績:
主要業績
単著・共著:
共著
発表年月:
2018年
DOI:
10.2169/internalmedicine.9035-17
会議属性:
指定なし
査読:
有り
リンク情報:

日本語フィールド

著者:
Iriyama N, Ohashi K, Hashino S, Kimura S, Nakaseko C, Takano H, Uchiyama M, Morita S, Sakamoto J, Sakamaki H, Inokuchi K
題名:
Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group.
発表情報:
Intern Med. 巻: 57 号: 1 ページ: 17-23
キーワード:
概要:
抄録:

英語フィールド

Author:
Iriyama N, Ohashi K, Hashino S, Kimura S, Nakaseko C, Takano H, Uchiyama M, Morita S, Sakamoto J, Sakamaki H, Inokuchi K
Title:
Efficacy of reduced-dose dasatinib as a subsequent therapy in patients with chronic myeloid leukemia in the chronic phase: The LD-CML study of the Kanto CML Study Group.
Announcement information:
Intern Med. Vol: 57 Issue: 1 Page: 17-23


Copyright © MEDIA FUSION Co.,Ltd. All rights reserved.